In last trading session, Moleculin Biotech Inc (NASDAQ:MBRX) saw 9.47 million shares changing hands with its beta currently measuring 1.29. Company’s recent per share price level of $0.84 trading at $0.2 or 30.56% at ring of the bell on the day assigns it a market valuation of $25.24M. That closing price of MBRX’s stock is at a discount of -460.71% from its 52-week high price of $4.71 and is indicating a premium of 70.24% from its 52-week low price of $0.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 15.65 million shares which gives us an average trading volume of 4.55 million if we extend that period to 3-months.
Moleculin Biotech Inc (NASDAQ:MBRX) trade information
Moleculin Biotech Inc’s shares saw a change of -80.23% in year-to-date performance and have moved 56.48% in past 5-day. Moleculin Biotech Inc (NASDAQ:MBRX) showed a performance of 21.95% in past 30-days. Number of shares sold short was 1.93 million shares which calculate 2.21 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 26.36% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 75.21% while estimates for its earnings growth in next 5 years are of 42.60%.
Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders
Insiders are in possession of 4.42% of company’s total shares while institution are holding 6.13 percent of that, with stock having share float percentage of 6.42%. Investors also watch the number of corporate investors in a company very closely, which is 6.13% institutions for Moleculin Biotech Inc that are currently holding shares of the company. ARMISTICE CAPITAL, LLC is the top institutional holder at MBRX for having 0.16 million shares of worth $0.55 million. And as of 2024-06-30, it was holding 6.1339 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 84418.0 shares on 2024-06-30. The number of shares represents firm’s hold over 3.3193 of outstanding shares, having a total worth of $0.3 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 30.31 shares of worth $25330.0 or 0.21% of the total outstanding shares. The later fund manager was in possession of 18.49 shares on May 31, 2025 , making its stake of worth around $15451.0 in the company or a holder of 0.13% of company’s stock.
